{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:52:34Z","timestamp":1747147954189,"version":"3.40.5"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cytometry Part B Clinical"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Pre\u2010analytical and analytical errors can threaten the reliability of flow cytometry (FC) results. A potential solution to some of these is the use of dry, pre\u2010mixed antibodies, such as the ClearLLab 10C system. The purpose of the present study was to compare the diagnostic performance of the ClearLLab 10C B cell tube with that of our standard laboratory practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We compared the diagnoses made with the ClearLLab 10C B cell tube (experimental strategy) with those made with standard laboratory practice (standard strategy). Samples were selected aiming for representation of the full spectrum of B cell disorders, with an emphasis on mature B cell malignancies, as well as healthy controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 116 samples (34 normal controls, 4 acute lymphoblastic leukemias, 54 mature lymphoproliferative disorders in peripheral blood and bone marrow, 3 myelomas, 6 bone marrow samples with involvement by lymphoma and 1 with elevated hematogone count, 14 lymph node samples, 1 cerebrospinal fluid, and 1 pleural effusion). There were two diagnostic errors (1.7%). The agreement between the two strategies in the percentage of CD19 cells and fluorescence intensity of CD5, CD19, CD20, CD200, and CD10 was very good.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this study, the ClearLLab 10C B cell tube performed similarly to our standard laboratory practice to diagnose and classify mature B cell malignancies.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cyto.b.21955","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:51:14Z","timestamp":1600822274000},"page":"519-530","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostic performance of the ClearLLab 10C B cell tube"],"prefix":"10.1002","volume":"100","author":[{"given":"Andrea","family":"Espasa","sequence":"first","affiliation":[{"name":"Hematology Laboratory Institut Catal\u00e0 d'Oncologia, Hospital Germans Trias i Pujol, Functional cytomics\u2010IJC, Universitat Aut\u00f2noma de Barcelona  Badalona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Torrents","sequence":"additional","affiliation":[{"name":"Laboratori Cel\u00b7lular Banc de Sang i Teixits  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Morales\u2010Indiano","sequence":"additional","affiliation":[{"name":"Clinical Laboratory ICS\u2010Metropolitana Nord, Core\u2010Hematology Department Hospital Germans Trias i Pujol  Badalona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura G.","family":"Rico","sequence":"additional","affiliation":[{"name":"Functional Cytomics, Josep Carreras Leukaemia Research Institute (IJC), Universitat Aut\u00f2noma de Barcelona, Badalona  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Bardina","sequence":"additional","affiliation":[{"name":"Functional Cytomics, Josep Carreras Leukaemia Research Institute (IJC), Universitat Aut\u00f2noma de Barcelona, Badalona  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agueda","family":"Ancochea","sequence":"additional","affiliation":[{"name":"Banc de Sang i Teixits Hospital Germans Trias i Pujol  Badalona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c0ngel","family":"Bistu\u00e9\u2010Rovira","sequence":"additional","affiliation":[{"name":"Functional Cytomics, Josep Carreras Leukaemia Research Institute (IJC), Universitat Aut\u00f2noma de Barcelona, Badalona  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Linio","sequence":"additional","affiliation":[{"name":"Banc de Sang i Teixits Hospital Germans Trias i Pujol  Badalona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minerva","family":"Raya","sequence":"additional","affiliation":[{"name":"Hematology Laboratory Institut Catal\u00e0 d'Oncologia, Hospital Germans Trias i Pujol, Functional cytomics\u2010IJC, Universitat Aut\u00f2noma de Barcelona  Badalona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Vergara","sequence":"additional","affiliation":[{"name":"Hematology Laboratory Institut Catal\u00e0 d'Oncologia, Hospital Germans Trias i Pujol, Functional cytomics\u2010IJC, Universitat Aut\u00f2noma de Barcelona  Badalona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Junc\u00e0","sequence":"additional","affiliation":[{"name":"Hematology Laboratory Institut Catal\u00e0 d'Oncologia, Hospital Germans Trias i Pujol, Functional cytomics\u2010IJC, Universitat Aut\u00f2noma de Barcelona  Badalona Spain"},{"name":"Functional Cytomics, Josep Carreras Leukaemia Research Institute (IJC), Universitat Aut\u00f2noma de Barcelona, Badalona  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan\u2010Ramon","family":"Grifols","sequence":"additional","affiliation":[{"name":"Banc de Sang i Teixits Hospital Germans Trias i Pujol  Badalona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Petriz","sequence":"additional","affiliation":[{"name":"Functional Cytomics, Josep Carreras Leukaemia Research Institute (IJC), Universitat Aut\u00f2noma de Barcelona, Badalona  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria\u2010Gloria","family":"Soria","sequence":"additional","affiliation":[{"name":"Laboratori Cel\u00b7lular Banc de Sang i Teixits  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-591X","authenticated-orcid":false,"given":"Marc","family":"Sorigue","sequence":"additional","affiliation":[{"name":"Hematology Laboratory Institut Catal\u00e0 d'Oncologia, Hospital Germans Trias i Pujol, Functional cytomics\u2010IJC, Universitat Aut\u00f2noma de Barcelona  Badalona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"cyto.b.21893","article-title":"Validation of a modified pre\u2010lysis sample preparation technique for flow cytometric minimal residual disease assessment in multiple myeloma, chronic lymphocytic leukemia, and B\u2010non Hodgkin lymphoma","author":"Bayly E.","year":"2020","journal-title":"Cytometry. Part B, Clinical Cytometry"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21371"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21854"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1077"},{"key":"e_1_2_7_6_1","first-page":"cyto.b.21935","article-title":"A multicenter study evaluation of the ClearLLab 10C panels","author":"Hedley B. D.","year":"2020","journal-title":"Cytometry. Part B, Clinical Cytometry"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21603"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21251"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.135"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20485"},{"volume-title":"510(k) substantial equivalence determination decision summary. Assay and instrument combination","author":"Inc. BC","key":"e_1_2_7_11_1"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.034"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.23901"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14901"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.44"},{"volume-title":"Improving the differential diagnosis of CD5+ B\u2010lymphoproliferative disorders","year":"2016","author":"Rawstron A.","key":"e_1_2_7_17_1"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21595"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21862"},{"key":"e_1_2_7_20_1","first-page":"cyto.b.21890","article-title":"FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study","author":"Sorigue M.","year":"2020","journal-title":"Cytometry. Part B, Clinical Cytometry"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21509"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21760"},{"key":"e_1_2_7_23_1","first-page":"385","article-title":"Flow cytometry in the differential diagnosis of CD10\u2010positive nodal lymphomas","volume":"51","author":"Sorigue M.","year":"2019","journal-title":"Laboratoriums Medizin"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001331"},{"volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2017","author":"Swerdlow S. H.","key":"e_1_2_7_25_1"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2017.03.011"}],"container-title":["Cytometry Part B: Clinical Cytometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cyto.b.21955","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cyto.b.21955","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cyto.b.21955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:07:26Z","timestamp":1693292846000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cyto.b.21955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1002\/cyto.b.21955"],"URL":"https:\/\/doi.org\/10.1002\/cyto.b.21955","archive":["Portico"],"relation":{},"ISSN":["1552-4949","1552-4957"],"issn-type":[{"type":"print","value":"1552-4949"},{"type":"electronic","value":"1552-4957"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"2020-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}